drugset

drugset / Trial / NCT00399451

Polidocanol Sclerotherapy of Pharynges for Obstructive Sleep Apnea (OSA) and Snoring Subjects(SS)

NCT00399451 ↗

Phase 1/2 Unknown 30 enrolled Liaoyang Central Hospital

Non-randomizedSingle-groupOpen-labelTreatment

Summary

The aim of this prospective study is to evaluate the results of polidocanol sclerotherapy of pharynx for OSAS \& SS,to reduce pharyngeal compliance.

Timeline

Start: 2006-12
Primary completion: —
Completion: 2009-06

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Polidocanol	Other / unclassified	1 %	Other

Indications